Results 131 to 140 of about 10,899 (169)
Some of the next articles are maybe not open access.
Lung infection with nontuberculous mycobacteria
Radiología (English Edition), 2023To describe the epidemiology and CT findings for nontuberculous mycobacterial lung infections and outcomes depending on the treatment.We retrospectively studied 131 consecutive patients with positive cultures for nontuberculous mycobacteria between 2005 and 2016. We selected those who met the criteria for nontuberculous mycobacterial lung infection. We
C, Cano Rodríguez +6 more
openaire +2 more sources
Clinical Manifestations of Nontuberculous Mycobacteria
2006Tuberculosis and leprosy have been widely recognized for over 2000 years and their causative organisms were identifi ed in the nineteenth century when microscopy fi rst became available. In contrast, nontuberculous mycobacteria (NTM), also known as atypical mycobacteria or mycobacteria other than Mycobacterium tuberculosis (MOTT), were not widely ...
Heyderman, Robert S, Clark, Julia
openaire +6 more sources
Chest, 2020
BACKGROUND Clofazimine has been regarded as a promising agent for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD). However, its overall effectiveness in vitro and in the clinic remains unknown.
N. Kwak +5 more
semanticscholar +1 more source
BACKGROUND Clofazimine has been regarded as a promising agent for the treatment of nontuberculous mycobacteria pulmonary disease (NTM-PD). However, its overall effectiveness in vitro and in the clinic remains unknown.
N. Kwak +5 more
semanticscholar +1 more source
Nontuberculous mycobacteria: Insights on taxonomy and evolution.
Infection, Genetics and Evolution, 2019Seventy years have passed since Ernest H. Runyon presented a phenotypic classification approach for nontuberculous mycobacteria (NTM), primarily as a starting point in trying to understand their clinical relevance.
C. Turenne
semanticscholar +1 more source
Nontuberculous mycobacteria in diffuse panbronchiolitis
Respirology, 2014AbstractBackground and objectiveNontuberculous mycobacterial (NTM) lung disease secondary to cystic fibrosis (CF) has been reported, but there is limited data about NTM prevalence in non‐CF bronchiectasis. We retrospectively investigated the prevalence of NTM associated with diffuse panbronchiolitis (DPB), a disorder also characterized by reduced ...
Takahiro, Tsuji +9 more
openaire +2 more sources
Laboratory diagnosis of nontuberculous mycobacteria
Clinics in Chest Medicine, 2002In conclusion, it is important to realize that there is no "stand alone" assay for the identification of NTM. Many new species may not be recognized in all assays. Newer molecular tests are more accurate for identification than phenotypic tests and have significantly improved turnaround time.
Akos, Somoskovi +4 more
openaire +2 more sources
Pathogenesis of nontuberculous mycobacteria infections
Clinics in Chest Medicine, 2002M avium is a microorganism well adapted to living in the environment and in different hosts. During the past 15 years, a substantial amount of information has been accumulated about the mechanisms used by M avium to cross the host's mucosal barrier, replicate inside cells, circumvent the host's immune response, and persist inside the host. It turns out
Jeffery, McGarvey, Luiz E, Bermudez
openaire +2 more sources
Pulmonary Infection with Nontuberculous Mycobacteria
American Review of Respiratory Disease, 1988Abstract Nontuberculous mycobacterial Infections (NTM) are being increasingly recognized as a cause of chronic pulmonary disease. We recently reviewed the clinical, radiologic, and bacteriologic presentation of 89 adult patients ill enough to have been hospitalized between 1981 and 1985 with the diagnosis of NTM.
M A, Contreras +3 more
openaire +2 more sources
American family physician, 1984
Nontuberculous mycobacteria are identified in almost half of the cultures reported positive for mycobacteria in clinical laboratories in the United States. While many represent saprophytic colonization or laboratory contamination, a significant number of these organisms are the agents of disease.
C B, Hartley, H, Yeager
openaire +1 more source
Nontuberculous mycobacteria are identified in almost half of the cultures reported positive for mycobacteria in clinical laboratories in the United States. While many represent saprophytic colonization or laboratory contamination, a significant number of these organisms are the agents of disease.
C B, Hartley, H, Yeager
openaire +1 more source
Environmental Sources of Nontuberculous Mycobacteria
Clinics in Chest Medicine, 2015Nontuberculous mycobacteria (NTM) include over 150 species. The source for human infection is the environment. NTM are normal inhabitants of soil and drinking water. NTM grow and persist in many buildings. They are not contaminants of drinking water, but members of the natural drinking water microbial population.
openaire +2 more sources